Japan also examined Picamilon extensively, but it is not extensively readily available to be a prescription drug. Regulations are much less distinct, and availability is limited. Users in Japan face challenges in accessing it because of legal constraints..[38] The outcomes of antibacterial and antifungal functions confirmed that several derivatives